Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal De Physiologie|January 1, 1984
The anterior wall of the third cerebral ventricle and homeostatic responses to dehydrationM J McKinley, M Congiu, D A Denton, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trialC Viscoli, E Castagnola, M T Van Lint, et al.
Leukemia & Lymphoma|May 9, 2001
Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patientsT Chisesi, P Polistena, A Contu, et al.
Bone Marrow Transplantation|November 1, 1988
Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working PartyA Bacigalupo, J Hows, E C Gordon-Smith, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 27, 2004
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, C De Souza, S Aversa, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1982
Alterations in osmotic but not pressor responses to ACTH by optic recess lesions in sheepB A Scoggins, J P Coghlan, M Congiu, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3J A Holmes, M Congiu, S Bonanzinga, et al.
Haematologica|February 22, 2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, P Coser, A M Congiu, et al.
Leukemia & Lymphoma|March 1, 1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapyA M Carella, E Prencipe, E Pungolino, et al.
Pageof 7